Table 2 Lymphocyte parameters' description and comparison for EM patients and healthy controls.

From: The role of the immune system and the biomarker CD3 + CD4 + CD45RA−CD62L− in the pathophysiology of migraine

Characteristic

Patients (49)

Controls (50)

Groups' comparison

P value

Effect Size

CD3 abs†

1.99 (1.59)

1.46 (0.74)

0.068

0.716

CD3 LEU (% from leukocytes)

28.88 (18.93)

22.14 (10.63)

0.062

0.687

CD4 + TEMRA (% from CD4 +)†

3.45 (5.25)

1.12 (2.76)

0.062

0.588

CD4 + TEMRA abs†

42.03 (83.59)

8.65 (29.17)

0.062

0.7

CD8 abs†

0.66 (0.49)

0.52 (0.34)

0.062

0.593

CD8 LEU (% from leukocytes)†

9.65 (5.51)

7.49 (4.59)

0.062

0.575

CD8 naive abs†

265.92 (223.44)

196.42 (175.85)

0.071

0.573

CD19 switched memory abs†

48.57 (41.66)

35.88 (22.45)

0.071

0.467

Lymphocytes (% from leukocytes)

39.53 (20.61)

31.56 (12.62)

0.062

0.652

  1. All characteristics are reported median (interquartile range).
  2. †Mann–Whitney U test used for non-normally distributed characteristics. Effect size is assessed by Cohen's d. All P values (two-sided alternative hypothesis) are reported after a Benjamini–Hochberg correction.
Back to article page